Sage Journals: Discover world-class research

Abstract

Index case Human Immunodeficiency Virus (HIV) testing is a voluntary procedure wherein service providers request index clients to enumerate all sexual partners, including biological children, before proceeding with Human Immunodeficiency Virus (HIV) testing. This approach has demonstrated efficacy as a case-finding strategy aimed at curbing future transmission. Through index testing, we can pinpoint partners and children with undiagnosed infections, thereby facilitating early identification of Human Immunodeficiency Virus (HIV) -positive children who are currently healthy. The study aimed to assess the acceptance of index-case Human Immunodeficiency Virus (HIV) testing and its associated factors among anti-retroviral therapy (ART) patients in public health facilities within the Gedeo zone, southern Ethiopia. The study employed a cross-sectional design with a document review. It involved 396 anti-retroviral therapy (ART) patients and utilized a pretested checklist to extract data from clients’ medical records. A simple random sampling technique was used to select anti-retroviral therapy (ART) facilities in the Gedeo zone. Data collection was done from anti-retroviral therapy (ART) patient documents by ODK-Kobo Collect form and data analysis was conducted using statistical package for social science (SPSS) version 25, with bivariate and multivariate analyses performed to identify associations between index case testing and associated factors. A significance level of P ≤ .05 was adopted. The findings were presented in textual format, tables, and graphs, providing a comprehensive overview of the results. The magnitude of the acceptance of the index case testing among anti-retroviral therapy (ART) patients was 240 (60.6% [95% CI: 56%-65%]). Concerning the adherence status of the index case, 156 (39.4%) and 54 (13.6%) had good and poor adherence, respectively. Duration on ART (AOR = 2.30 [95% CI: 1.86, 6.12]), HIV disclosure (AOR = 36.19 [95% CI: 7.26, 180.44]), and good ART adherence status (AOR = 14.52 [95% CI: 2.10, 100.2]) are found to be factors significantly associated with acceptance of index case testing. The study findings indicated that the overall acceptance rate of index case testing was 60%, which falls short of the national benchmark minimum acceptance rate of 95%. Factors significantly linked to the acceptance of index case testing included the duration of ART usage, disclosure of HIV status, and adherence to ART medication. To improve the magnitude of the index case testing, the government and other NGOs working in these areas should work on health education, awareness creation, and improvement of treatment adherence. Ensure the sustainability of ICT services in ART facilities and the provision of quality HIV index case testing services.

Keywords

index case HIV testing ART associated factors Ethiopia HIV testing acceptance

What do we already know about this topic?

The absence of the index case HIV testing increases the transmission of Human Immunodeficiency Virus (HIV) and makes the prevention of the disease difficult.

How does your research contribute to the field?

This research will contribute to our understanding of index-case Human Immunodeficiency Virus (HIV) testing procedures in high-prevalence and densely inhabited locations.

What are your research’s implications for theory, practice, or policy?

Through raising community knowledge of the Human Immunodeficiency Virus (HIV), especially among those who have been exposed to the virus, this project will help develop index-case HIV testing methods.

Introduction

Index case (ICT) Human Immunodeficiency Virus (HIV) testing is a voluntary practice where the service provider asks index clients to list their entire sexual partner within the past year and biological children and offers and conducts HIV testing.^1,2 It is a high-yield, targeted testing approach for identifying and linking new HIV-infected individuals at an early stage to care and treatment services and linking HIV-negative individuals at risk for HIV to prevention services, and it has made a significant contribution to increasing the number of people diagnosed with HIV.³ This approach needs to be optimally utilized for case detection and to break the HIV transmission cycle by offering HIV testing to individuals who are exposed to HIV and linking them to care and treatment in the event of HIV-positive results.^3,4

Since the onset of the HIV epidemic, an estimated 85.6 million people have been infected with the virus, resulting in approximately 40.4 million deaths globally. By the end of 2022, about 39.0 million people were living with HIV worldwide. In 2022, Africa had an estimated 25.6 million people living with HIV. Among these individuals, 90% were aware of their HIV status, 82% were receiving antiretroviral treatment (ART), and 76% had achieved viral suppression. Approximately 20.9 million people were on antiretroviral therapy during this period. The number of new HIV infections in Africa was estimated at 660 000, with an incidence rate of 0.57 per 1000 uninfected population. These figures indicate significant progress in HIV prevention, testing, and treatment across the continent. However, despite these achievements, challenges remain in ensuring universal access to HIV prevention, testing, and treatment services to further reduce the burden of HIV/AIDS in Africa.^5,6

HIV partner notification helps identify individuals with undiagnosed HIV and connects them to antiretroviral therapy (ART), reducing the disease's impact on their health and interrupting transmission chains.^7
-9 The UNAIDS has established the 95-95-95 target, a universal goal to curb HIV transmission and enhance the timeliness of ART treatment. Meeting these primary objectives is expected to pave the way for achieving subsequent targets.^10,11

Index case HIV testing began in Africa around the early 2000s as a strategy to identify individuals who might not otherwise get tested and to reach those at higher risk of HIV infection. In Ethiopia, this program was launched in 2017 with a similar goal of reducing HIV transmission.¹² Index case HIV testing provides critical data for stakeholders, helping them to focus on and plan strategies to improve the acceptance of this testing method, thereby disrupting the chain of HIV transmission.³ Index case HIV testing provides critical data for stakeholders, helping them to focus on and plan strategies to improve the acceptance of this testing method, thereby disrupting the chain of HIV transmission.¹³ This study, therefore, aimed to determine the acceptance rate of index case testing and the factors influencing its acceptance among ART patients.

Objectives of the Study

General Objective

To determine the acceptance of index-case HIV testing and associated factors among HIV-positive patients among anti-retroviral therapy patients in public health facilities in the Gedeo zone, southern Ethiopia.

Specific Objectives

(1) To determine the magnitude of HIV index case testing among index cases on ART follow-up in ART facilities in Gedeo Zone public health facilities

(2) To identify factors associated with HIV index case testing on ART follow-up in Gedeo Zone public health facilities

Methodology

Study Area and Period

The research was carried out in the Gedeo zone of southern Ethiopia at public health facilities that offer anti-retroviral therapy (ART) services. The Gedeo Zone, situated approximately 360 km from Ethiopia’s capital, Addis Ababa, has a population of 1,166,163, consisting of 571 420 males and 594 743 females. ART services are available only at public health facilities within the zone, which includes Dilla Teaching Hospital, 3 primary hospitals (Gedeb, Bule, and Yirga Chefe), and 3 health centers (Haroresa, Wonago, and Chelelecktu). The study spanned from July 1 to August 30, 2023.

Study Design

For this study, we employed a cross-sectional study design coupled with a document review. This approach was chosen as it was the only viable method to obtain data on estimated study participants within the three-month collection period. Secondary data from document reviews of ART patients were utilized to fulfill this requirement.

Source Population

The source population was HIV-positive patients who had at least one contact and had enrolled in ART service for the last 5 years at ART facilities in the Gedeo zone, South Ethiopia region.

Study Population

The study population was sampled from patient cards who were elicited for HIV index contact testing during the study period at public health facilities, in the Gedeo zone, South Ethiopia region

Inclusion and Exclusion Criteria

Inclusion criteria

The inclusion criteria focused on HIV index cases with at least 1 index who is either a partner (married or non-spousal) or a biological child.

Exclusion criteria

Excluded from the study were patient medical records from the ART unit that did not contain information about index partners or children. Additionally, index clients not documented in the index testing registers were also excluded.

Sample Size Determination

The sample size for the initial objective was determined using the prevalence of HIV index client testing (P), which was sourced from a cross-sectional study on disclosure conducted at Jimma Specialized Hospital. This study reported a prevalence of 37.7%. Based on this prevalence, the sample size was calculated using the single population proportion formula:

n = \frac{{(Z α \ 2)}^{2} P (1 - P)}{{(d)}^{2}}

n = \frac{{(1.96)}^{2} 0.377 (1 - 0.377)}{{(0.05)}^{2}}

n = 360

Where, n = the desired sample size, Z = percentiles of the standard normal distribution corresponding to 95% of the confidence level

P = there is research conducted in Jimma (0.377)¹⁴ and d = marginal error between sample and population was taken as 5%. Hence, the calculated total sample size was 360 with adding a 10% non-response rate, a total required sample size was 360 + 36 = 396.

Sample Size Calculation for the Second Objective

The sample size for assessing factors associated with index case HIV testing among adult ART clinic attendees was determined based on several considerations, including significant factors associated with outcome variables, a two-sided confidence level of 95%, a margin of error of 5%, and a power of 80%. This calculation was performed using Open Epi Info version 7. The possible calculated sample sizes for selected factors are depicted below (Table 1).

Table 1.

Sample Size Calculation for Different Factors Associated with Acceptance of Index Case HIV Testing among Adult ART Clinic Attendants at Gedeo Zone, Southern Ethiopia, 2023.

Factors	AOR	Acceptance of index case testing		Sample size	References
Factors	AOR	Yes	No	Sample size	References
Year since Diagnosis	1.348	13.8%	1.7%	184	Johnson¹³
Disclosure status	6.20	19.5%	35.5%	338	Rentz et al.¹⁴
Sex	1.7	66.9%	33.1.%	18	Edosa et al.¹⁵

Sampling Procedure

For this study, public health facilities offering Antiretroviral Therapy (ART) services in the Gedeo zone were included. This comprised 4 hospitals (1 General Hospital and 3 primary hospitals) and 1 health center, selected purposively due to their high HIV patient load. The documents of study participants from all selected ART facilities in Gedeo were proportionally allocated based on the history of the case. Subsequently, a simple random sampling technique was employed to select 7 health facilities with ART services from the Gedeo zone (Figure 1).

Figure 1.

Proportionate allocation of the sample size among public health facilities with ART service in Gedeo Zone, Southern Ethiopia 2023.

Variably of the Study

Dependent variable

Acceptance of HIV index testing

Independent variables

The study collected data on various socio-demographic and family-related factors, including (age, residence, educational status, marital status distance to health facility), family-related factors (number of children and family size), disclosure status, duration on ART, and clinical stage of disease.

Operational Definitions

Index case

The index case in this study refers to an individual who tested HIV positive during HIV Testing and Counseling (HTC) service at the health facility.^15,16

Acceptance

Acceptance is defined as when an indexing client agrees to the testing of their family members (household members) and consent from the index client is obtained, indicating approval for sharing the test results of their partner and/or children, which are then documented in the individual’s folder.¹⁷

Index case HIV testing

Index case HIV testing encompasses offering HIV testing to all individuals who have been exposed to HIV by the index case.

Data Collection Tool and Procedure

The data extraction checklist, developed by the principal investigator, was meticulously crafted after a comprehensive review of relevant literature and an assessment of various ART follow-up cards and registration books. Subsequently, this checklist was integrated into ODK-Kobo software¹⁸ for streamlined data collection. The tool comprised 4 distinct sections: Socio-demographic factors (including age, residence, educational status, marital status, and distance to a health facility), family-related factors (such as the number of biological children and overall family size), care and treatment-related factors (encompassing duration on ART and disclosure status), and service delivery-related factors (including the WHO clinical stage of the disease and adherence status).

Data extraction was conducted through a systematic review of documents, with the collected information inputted directly into the ODK-Kobo Collect form. The team of data collectors consisted of 5 BSc nurses with experience in ART clinics, who were working outside of the study, and 1 MSc supervisor.

Data Quality Assurance

A comprehensive two-day training session was conducted. The quality of the data was meticulously ensured throughout the data collection process. To maintain high standards, 5% of the cards from each data collection site were randomly selected by the principal investigator for a thorough examination. During data collection, the data collectors rigorously assessed the completeness, consistency, and accuracy of the data to identify any discrepancies or errors. Additionally, the investigators conducted further evaluations of the submitted data before entering it into the software.

Data Processing and Analysis

The data collected through ODK-Kobo Collect was exported into SPSS version 25 for further analysis. Various cleaning methods within the software were employed to ensure data accuracy and consistency. Checks and cleaning processes were carried out to rectify any inaccuracies or inconsistencies before proceeding with the final analysis. The normality of the data was assessed using graphical and statistical methods such as the Shapiro-Wilk test.¹⁹ Bivariate and multivariate analyses were conducted to identify factors associated with the acceptance of index case testing. The significance level was set at P ≤ .05 to determine statistically significant associations. Finally, the findings were presented using a combination of text, frequency tables, and graphs to effectively communicate the results of the study.

Ethical Considerations

Ethical clearance for this study was obtained from the Research and Ethical Committee (REC) of the Department of Public Health, Pharma College, Hawasa campus. Additionally, permission was sought and obtained from the respective health institutions before accessing and reviewing the registration books. Identifying information such as names and telephone numbers were not extracted from the checklist. Instead, individual unique ART numbers, specifically arranged for this study, were utilized. Access to the documents of ART patients included as study participants was restricted solely to the investigator and authorized data collectors to ensure confidentiality. Following data extraction, the records were promptly returned to the archive and securely placed on their designated shelves.

Result

Socio-Demographic Characteristics of the Study Participants

In this study, a total of 396 ART patient cards were reviewed. The mean age of the index cases who participated in the study was 35.89 years, with a standard deviation of 28.289 years. The majority of the study participants fell within the age group of 25-34 years, constituting 49.0% of the total. In terms of residence, 246 (62.1%) of the participants were from rural areas, while 150 (37.9%) were from urban areas. Regarding educational status, the largest proportion of participants (40.0%) had received primary education (Table 2).

Table 2.

Sociodemographic Characteristics of the Study Participants for Index Case HIV Testing among Adult ART Patient from Selected Public ART Facilities in Gedeo Zone, Southern Ethiopia (n = 396), 2023.

Variable	Response	Frequency	%
Age group	18-24	29	7.3
	25-34	194	49.0
	≥35	173	43.7
Sex	Female	244	61.6
Sex	Male	152	38.4
Residence	Rural	246	62.1
Residence	Urban	150	37.9
Educational status	No formal education	154	38.9
	Primary education	190	40.0
	Secondary education	41	10.4
	Diploma and above	11	2.8
Marital status of index client	Divorced	51	12.9
	Married	284	71.7
	Single	1	0.3
	Widowed	60	15.2
Occupational status of index client	Employed	24	6.1
	Farmer	118	29.8
	Merchant	80	20.2
	Other (daily labor, housewife, student)	174	43.9
Duration on ART	<12 months	155	39.1
	≥12 months	241	60.9

HIV/AIDS-Related Characteristics of the Study Participants

The acceptance rate of index case testing among ART patients was 240, 60.6% (95% CI: 56%-65%). In terms of the WHO clinical staging of the disease, the majority of index cases were classified under stage 1, comprising 292 (73.7%) individuals. Additionally, 56 (14.1%) were categorized as stage 2, 44 (11.1%) as stage 3, and 4 (1.0%) as stage 4 (Figure 2). Regarding adherence status, 156 (39.4%) index cases demonstrated good adherence, while 54 (13.6%) exhibited poor adherence (Figure 3). It is noteworthy that all ART patients were offered index case HIV testing services. Among the index cases with partners, which accounted for 288 (72.7%), a majority of 176 (61.1%) partners underwent HIV testing, and 126 (62%) of them tested positive for HIV. Importantly, the majority of HIV-positive partners were successfully linked to care and treatment services, totaling 122 individuals (96.82%) (Table 3).

Figure 2.

The WHO clinical staging of the disease of index cases in Gedeo Zone public ART facilities.

Figure 3.

The adherence status of the index cases on ART in Gedeo zone public ART facilities.

Table 3.

HIV-Related Characteristics of Index Case Relatives in Public Health Facilities in Gedeo Zone, Southern Ethiopia.

Variable	Response	Frequency	%
HIV status Disclosure to family	Disclosed	211	53.3
HIV status Disclosure to family	Not disclosed	185	46.7
Index case having partner	Yes	288	72.7
Index case having partner	No	108	27.3
Sex of the index case partner	Female	136	34.3
Sex of the index case partner	Male	152	38.4
Educational status of partner	No formal education	124	31.3
	Primary education	117	29.5
	Secondary education	44	11.1
	Diploma and above	2	0.5
HIV test for partner	Yes	176	61.1
HIV test for partner	No	112	38.8
Test result of partner	Negative	50	28.4
Test result of partner	Positive	126	61.59
Linkage of the HIV positive partner to care and treatment	Yes	122	96.82
Linkage of the HIV positive partner to care and treatment	No	4	3.28
Index case who have children <19 years old	Yes	318	80.3
Index case who have children <19 years old	No	78	19.7
No of<19 years does index client have	Yes	629	100
No of<19 years does index client have	No	0
No of children <19 years tested for HIV	Yes	362	58
No of children <19 years tested for HIV	No	267	42
Test result of <19 children tested for HIV	Positive	17	4.69
Test result of <19 children tested for HIV	Negative	345	95.3
Linkage of the children to care and treatment	Positive	16	94.1
	No	1	5.88

Factors Associated With Acceptance of the Index Case Testing

In bivariate logistic regression, 5 variables, including residence 1.6 (95% CI: 1.087, 2.54), duration on AR 10.98 (95% CI: 6.824, 17.69), HIV disclosure 146.4 (95% CI: 60.05, 357.02), good adherence to ART 166.34 (95% CI: 51.93, 532.76), and educational status on index case partner 6.9 (95% CI: 3.53, 13.53), have an association with acceptance of the index case testing.

Those above-listed variables and other variables with a P-value ≤ .25 undergo multivariate logistic regression. Accordingly, in multivariate analysis, 3 variables showed a significant association with acceptance of index case testing among ART patients with a duration on ART treatment of more than 12 months that was 2 times higher compared with patients on ART for less than 12 months (AOR = 2.3; 95% CI: 1.86, 6.12). HIV disclosure was 36.19 (95% CI: 7.26, 180.44), and good ART adherence status was 14.52 (95% CI: 2.10, 100.2) (Table 4).

Table 4.

The Factors Associated With Acceptance of HIV Index Case Testing Among ART Patient from Selected Public ART Facilities in Gedeo Zone, Southern Ethiopia (n = 396), 2023.

Variable	Categories	Acceptance of the index case testing		COR (95% CI)	AOR (95% CI)
Variable	Categories	Accepted	Not accepted	COR (95% CI)	AOR (95% CI)
Residence	Rural	138	108	1	1
Residence	Urban	102	48	1.6 (1.087, 2.54)	1.56 (0.602, 3.971)
WHO clinical stage	Stage 1	190	102	1	1
	Stage 2	26	30	0.45 (0.26, 0.82)	0.447 (0.133, 1.509)
	Stage 3	22	22	0.537 (0.28, 1.016)	0.672 (0.179, 2.51)
	Stage 4	2	2	0.53 (0.75, 3.86)	10.27 (0.08, 1228.7)
Duration on ART	<12 months	44	111	1	1
Duration on ART	≥12 months	196	45	10.98 (6.824, 17.69)	2.302 (1.86, 6.12)
HIV disclosure	Disclose	205	6	146.4 (60.05, 357.02)	36.19 (7.26, 180.4)
HIV disclosure	Not disclosed	35	150	1	1
ART adherence status	Good	173	13	166.34 (51.93, 532.76)	14.52 (2.10, 100.2)
	Fair	63	93	8.46 (2.912, 24.62)	7.56 (1.24, 45.9)
	Poor	4	50	1	1
Index case having partner	Yes	183	105	0.64 (0.41, 1.003)	—
Index case having partner	No	57	51	1	1
Educational status of index case partner	No formal education	110	14	6.909 (3.53, 13.53)	—
	Primary education	60	57	0.926 (0.549, 1.561)	0.505 (0.22, 11.52)
	Secondary education	11	33	0.293 (0.134, 0.639)	1.40 (0.51, 13.05)
	Diploma and above	1	1	1	1
Partner tested for HIV	Yes	175	1	1	1
Partner tested for HIV	No	8	104	156.579 (21.12, 1158.7)	—

OR = odds ratio; CI = confidence interval.

Discussion

The present study revealed an acceptance rate of index case testing at 60.6%, which is lower compared to similar studies conducted in West Ethiopia (85.2%)¹⁵ and refuge camps in southern Ethiopia 73%.¹⁷ Additionally, it falls below acceptance rates reported in other studies conducted in Ethiopia 73%,²⁰ Tanzania 96.6%,²¹ and Zimbabwe 95%.²² Several factors may contribute to this discrepancy, including differences in study design, methodology, data collection tools, and study populations. Additionally, variations in healthcare infrastructure, access to services, and community awareness about HIV testing may influence acceptance rates across different settings. Conversely, the acceptance rate observed in this study was higher than that reported in another study conducted in Ethiopia (53%).²³ This difference could be attributed to variations in the study population and the study design utilized.

The odds of accepting index case testing among patients on ART for more than 12 months were found to be 2.3 times higher (AOR = 2.3; 95% CI: 1.86, 6.12) compared to those on ART for less than 12 months. This finding aligns with studies conducted in West Ethiopia, Jimma, Ethiopia,²⁴ and Gojam, Ethiopia.²⁵ It is plausible that as the duration of ART treatment increases, index-case patients become more aware of the risks to their family members. Additionally, prolonged ART treatment may reduce their fear and experience of discrimination, thus increasing their willingness to undergo index case testing.

Similarly, the acceptance of index case testing among patients who disclosed their HIV status was found to be significantly higher (AOR = 36.19, 95% CI: 7.26, 180.44) compared to patients who did not disclose their HIV status. This finding is consistent with a study conducted in West Ethiopia.²⁰ The act of disclosing one’s HIV status may empower patients to advocate for HIV testing among their family members, thereby increasing acceptance rates for index case testing.

Likewise, index cases with good ART adherence status were found to have a significantly higher chance (AOR = 14.52; 95% CI: 2.10, 100.2) of accepting index case testing compared to patients with poor adherence to ART. This may be attributed to the fact that patients with good adherence understand the benefits of ART care, which in turn motivates them to advocate for HIV testing among their contacts.

This study aimed to assess the acceptance rate of index case testing and identify associated factors among patients receiving ART treatment. The findings revealed that the acceptance rate of index case testing in the study area was lower than the global average. Additionally, the study identified factors associated with the acceptance of index case testing, which could serve as valuable evidence for enhancing acceptance rates. By shedding light on the challenges and determinants of index case testing acceptance among ART patients, this study contributes to the understanding of HIV prevention strategies in the local context. The identified factors can inform targeted interventions and programs aimed at improving acceptance rates and ultimately reducing HIV transmission within communities.

Strength of the Study

Comprehensive coverage of all ART facilities in the Gedeo zone ensures a representative sample, enhancing the study’s external validity.

Triangulation of incomplete data from various sources such as ICT registration books and SMART care clients' databases improves the reliability and completeness of the dataset, enhancing the study's robustness.

Weakness of the Study

The inability to include important variables due to the nature of the data source limits the depth of the analysis and may lead to potential biases or confounding factors not being accounted for.

Dependence on secondary data sources for triangulation may introduce errors or inconsistencies, impacting the accuracy of the findings.

Conclusion

The study reveals a concerning low overall acceptance rate of index case testing, highlighting the need for targeted interventions to improve HIV testing uptake in the Gedeo zone.

Factors such as duration of ART, HIV status disclosure, and medication adherence emerge as significant determinants of acceptance, providing valuable insights for designing targeted interventions.

Recommendations for improving index case testing rates include health education, awareness campaigns, and efforts to enhance treatment adherence, underscoring the importance of multi-faceted approaches to HIV care.

Ensuring the sustainability of ICT services and maintaining quality in HIV index case testing are essential for long-term improvements in HIV testing and care outcomes in the region.

Footnotes

Acknowledgements

We would like to thank the Gedeo Zone Health Office and Pharma college of Health Science, Hawassa campus.

Abbreviations/Acronyms

ART: Antiretroviral Therapy; ARV: Anti-retroviral; EDHS: Ethiopian Demographic Health Survey; EPHI: Ethiopian Public Health Institution; HTS: HIV Testing Service; ICT: Index Case HIV Testing; PLHIV: People Living with HIV/AIDS; PNS: Partner Notification Service

Author Contributions

Eliyas Assefa: Involved in the conception, and proposal development and designed the experiments; Performed the experiments; Analyzed and interpreted the data.

Zerihun Figa: Contributed materials, analysis tools, or data and wrote the paper. Both authors read and approved the final manuscript

Availability of Data and Materials

The authors presented the necessary data in the manuscript. The dataset associated with the conclusions of this article is available from the authors upon reasonable request.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethics,Approval,and Consent to Participate

Ethical clearance for this research was obtained from the research and ethical committee (REC) of the Department of Public Health, Pharma College, Hawasa, campus. Ethical approval number 053/2023.

Informed Consent

Not applicable

Consent for Publication

Not applicable.

ORCID iD

Zerihun Figa

References

Essajee

Putta

Brusamento

Penazzato

Mark

Family-Based Index Case Testing to Identify Children With HIV. World Health Organization;2020.

Targets

. EpiC spotlight on HIV self-testing for COP 21. 2020. Accessed September 25, 2023. PA00X92C.pdf (usaid.gov)

Federal Ministry of Health Ethiopia. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. FMOH; 2018.

South African National Department of Health. Standard operating procedures for HIV index testing services. 2020. Accessed September 26, 2023. https://www.health.gov.za/index.php/hiv-aids-tb-and-maternal-child-and-womens-health

Korenromp

Sabin

Stover

, et al. New HIV infections among key populations and their partners in 2010 and 2022, by world region: a multisources estimation. J Acquir Immune Defic Syndr. 2024;95(1S):e34-e45.

Stover

Glaubius

Teng

, et al. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Med. 2021;18(10):e1003831.

Tafuma

Mahachi

Dziwa

, et al. Time taken to link newly identified HIV positive clients to care following a home-base index case HIV testing: experience from two provinces in Zimbabwe. PLoS One. 2018;13(8):e0201018.

Dalal

Johnson

Fonner

, et al. Improving HIV test uptake and case finding with assisted partner notification services. Aids. 2017;31(13):1867-1876.

Katbi

Adegboye

Adedoyin

, et al. Effect of clients Strategic Index Case Testing on community-based detection of HIV infections (STRICT study). Int J Infect Dis. 2018;74:54-60.

10.

Frescura

Godfrey-Faussett

Feizzadeh

, et al. Achieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS One. 2022;17(8):e0272405.

11.

Musee

Aida

, et al Intensified HIV case finding through index case testing in Kenya: a model of success. Accessed April 12, 2023. aPNS-brief-v2.pdf (pedaids.org)

12.

Africa

Demographic Patterns of HIV Testing Uptake in Sub-Saharan Africa DHS Comparative Reports 30. USAID; 2013.

13.

Johnson

Consolidated Guidelines on HIV Testing Services: 5Cs: Consent, Confidentiality, Counselling, Correct Results and Connection. WHO;2015.

14.

Rentz

Hood

Katz

, et al. Pilot integration of HIV screening and healthcare settings with multi-component social network and partner testing for HIV detection. Curr HIV Res. 2017;15(3):244-249. doi:10.2174/1570162X15666170615123455

15.

Edosa

Merdassa

Turi

Acceptance of index case HIV testing and its associated factors among HIV/AIDS clients on ART follow-up in West Ethiopia : a multi-centered facility-based cross-sectional study. HIV AIDS (Auckl). 2022;14:451-460. doi:10.2147/HIV.S372795

16.

Simon

Flick

Kim

Sabelli

Tembo

Phelps

BR.

Family testing: an index case finding strategy to close the gaps in pediatric HIV diagnosis. JAIDS J Acquir Immune Defic Syndr. 2018;78(Suppl 2):S88-S97. doi:10.1097/QAI.0000000000001731

17.

Wegu

Sileshi

Melis

Assessment of index case family testing among adults attending art clinic at kule refugee camp, Southwest Ethiopia: 2021. HIV AIDS (Auckl). 2022;14:13-21.

18.

KoboToolbox. Kobo Collect, version 2023.1. KoboToolbox; 2024. Accessed May 29, 2024. https://www.kobotoolbox.org/

19.

Mishra

Singh

Pandey

Mishra

Pandey

Descriptive statistics and normality tests for statistical data. Ann Card Anaesth. 2019;22(1):67. doi:10.4103/aca.ACA_157_18

20.

Haileyesus

Acceptance of Index Case HIV Testing and Counseling Among HIV Patients Under Ossa Care and Support Outlets and Zewditu Memorial Hospital, Addis Ababa. Addis Ababa University; 2013.

21.

Kahabuka

Plotkin

Christensen

, et al. Addressing the first 90: a highly effective partner notification approach reaches previously undiagnosed sexual partners in Tanzania. AIDS Behav. 2017;21(8):2551-2560. doi:10.1007/s10461-017-1750-6

22.

Mahachi

Muchedzi

Tafuma

, et al. Sustained high HIV case-finding through index testing and partner notification services: experiences from three provinces in Zimbabwe. J Int AIDS Soc. 2019;22(12):45-53. doi:10.1002/jia2.25414

23.

Fetene

Ayalew

Acceptance of referral for partners by clients testing positive for human immunodeficiency virus. HIV AIDS (Auckl). 2013;5:19-28. doi:10.2147/HIV.S39250

24.

Tesfaye

Darega

Belachew

Abera

HIV positive sero-status disclosure and its determinants among people living with HIV/AIDS following ART clinic in Jimma University Specialized Hospital, Southwest Ethiopia: a facility- based cross-sectional study. Arch Public Heal. 2018;76:1.

25.

Tucho

Tekelehaimanot

Habte

MB.

Disclosure status and associated factors among children on antiretroviral therapy in Ethiopia. Pediatr Heal Med Ther. 2021;12:299-306.

Acceptance of the Index Case HIV Testing and Associated Factors among Anti-Retroviral Therapy Patients in Public Health Facilities in Gedeo Zone,Southern Ethiopia. Cross-Sectional Study Design with Document Review

Abstract

Keywords

Introduction

Objectives of the Study

General Objective

Specific Objectives

Methodology

Study Area and Period

Study Design

Source Population

Study Population

Inclusion and Exclusion Criteria

Inclusion criteria

Exclusion criteria

Sample Size Determination

Sample Size Calculation for the Second Objective

Sampling Procedure

Variably of the Study

Dependent variable

Independent variables

Operational Definitions

Index case

Acceptance

Index case HIV testing

Data Collection Tool and Procedure

Data Quality Assurance

Data Processing and Analysis

Ethical Considerations

Result

Socio-Demographic Characteristics of the Study Participants

HIV/AIDS-Related Characteristics of the Study Participants

Factors Associated With Acceptance of the Index Case Testing

Discussion

Strength of the Study

Weakness of the Study

Conclusion

Footnotes

Acknowledgements

Abbreviations/Acronyms

Author Contributions

Availability of Data and Materials

Declaration of Conflicting Interests

Funding

Ethics,Approval,and Consent to Participate

Informed Consent

Consent for Publication

ORCID iD

References